Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Generation of demyelination models by targeted ablation of oligodendrocytes in the zebrafish CNS.
Interferon beta-1b in the treatment of multiple sclerosis: final outcome of the randomized controlled trial. The IFNB Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group.
Teriflunomide effect on immune response to influenza vaccine in patients with multiple sclerosis.
Channelopathy-related SCN10A gene variants predict cerebellar dysfunction in multiple sclerosis.
Circulating miR-150 in CSF is a novel candidate biomarker for multiple sclerosis.
Beneficial actions of the anti-inflammatory dimethyl fumarate in glioblastomas.
Magnetization transfer ratio in the delayed-release dimethyl fumarate DEFINE study.
EU regulator warns on possible MS drugs side effects
Quality of life outcomes with BG-12 (dimethyl fumarate) in patients with relapsing-remitting multiple sclerosis: The DEFINE study.
Multiple sclerosis in 2014: Progress in MS-classification, mechanisms and treatment.
Leflunomide: mode of action in the treatment of rheumatoid arthritis.
Gordon Research Conference on In Vivo Magnetic Resonance
Polymorphism in Leptin and Leptin Receptor Genes May Modify Leptin Levels and Represent Risk Factors for Multiple Sclerosis.
Glycoproteins as targets of autoantibodies in CNS inflammation: MOG and more.
Mitoxantrone: benefits and risks in multiple sclerosis patients.
Cognitive Impairment in Multiple Sclerosis: Clinical Manifestation, Neuroimaging Correlates, and Treatment.
Pattern of remyelination in the CNS.
Biogen Idec reports death of patient on its MS pill
Dimethyl fumarate suppresses Theiler's murine encephalomyelitis virus - induced demyelinating disease by modifying Nrf2-Keap1 pathway.
Protein microarrays guide tolerizing DNA vaccine treatment of autoimmune encephalomyelitis.
Effectiveness and cost-effectiveness of interferon beta and glatiramer acetate in the UK Multiple Sclerosis Risk Sharing Scheme at 6 years: a clinical cohort study with natural history comparator.
Intravenous mitoxantrone and cyclophosphamide as second-line therapy in multiple sclerosis: an open-label comparative study of efficacy and safety.
Infectious mononucleosis at the United States Military Academy. A prospective study of a single class over four years.
Interferon-beta is a potent promoter of nerve growth factor production by astrocytes.
Low-contrast acuity measures visual improvement in phase 3 trial of natalizumab in relapsing MS.

Pages